DUXAP8 is a biomarker and therapeutic target of various cancers that is upregulated in GC, promotes cell proliferation and migration, and then accelerates the development of GC32, and this study verified the upregulation of DUXAP8 in GC. This evidence concerns the gene DUXAP8 and cancer.